-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Citius Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q4 2023.
- Citius Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$6.14M, a 27.2% decline year-over-year.
- Citius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$29.1M, a 2.46% decline from 2022.
- Citius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$28.4M, a 17% decline from 2021.
- Citius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$24.3M, a 43.2% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)